NasdaqGS:GERNBiotechs
Is Geron (GERN) Quietly Reframing Its Oncology Commercialization Strategy With New Board Appointments?
Geron Corporation recently expanded its Board of Directors by appointing Patricia S. Andrews and Constantine Chinoporos, both experienced leaders in oncology commercialization and biopharma deal-making.
The addition of directors with deep oncology launch and business development backgrounds may be particularly relevant as Geron progresses RYTELO and evaluates future growth options.
Next, we’ll explore how Geron’s addition of seasoned oncology and business development leaders could influence...